Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012 (2012), Article ID 616384, 9 pages
http://dx.doi.org/10.1155/2012/616384
Research Article

Changes in the Monocytic Subsets CD14dimCD16+ and CD14++CD16 in Chronic Systolic Heart Failure Patients

1Heart Failure Center, Division of Cardiology, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, 34362 Haifa, Israel
2Immunology Research Unit, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, 34362 Haifa, Israel
3Department of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, 34362 Haifa, Israel

Received 22 August 2012; Revised 11 October 2012; Accepted 25 October 2012

Academic Editor: Chiou-Feng Lin

Copyright © 2012 Offer Amir et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. M. Dunlay, Y. Gerber, S. A. Weston, J. M. Killian, M. M. Redfield, and V. L. Roger, “Prognostic value of biomarkers in heart failure application of novel methods in the community,” Circulation: Heart Failure, vol. 2, no. 5, pp. 393–400, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. O. Amir, H. Paz, O. Rogowski et al., “Serum oxidative stress level correlates with clinical parameters in chronic systolic heart failure patients,” Clinical Cardiology, vol. 32, no. 4, pp. 199–203, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Khaper, S. Bryan, S. Dhingra et al., “Targeting the vicious inflammation-oxidative stress cycle for the management of heart failure,” Antioxidants and Redox Signaling, vol. 13, no. 7, pp. 1033–1049, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Rogowski, S. Shnizer, R. Wolff, B. S. Lewis, and O. Amir, “Increased serum levels of oxidative stress are associated with hospital readmissions due to acute heart failure,” Cardiology, vol. 118, no. 1, pp. 33–37, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. S. M. Dunlay, S. A. Weston, M. M. Redfield, J. M. Killian, and V. L. Roger, “Tumor necrosis factor-α and mortality in heart failure: a community study,” Circulation, vol. 118, no. 6, pp. 625–631, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Bozkurt, D. L. Mann, and A. Deswal, “Biomarkers of inflammation in heart failure,” Heart Failure Reviews, vol. 15, no. 4, pp. 331–341, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. B. J. Wrigley, G. Y. H. Lip, and E. Shantsila, “The role of monocytes and inflammation in the pathophysiology of heart failure,” European Journal of Heart Failure, vol. 13, no. 11, pp. 1161–1171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. F. L. van de Veerdonk and M. G. Netea, “Diversity: a hallmark of monocyte society,” Immunity, vol. 33, no. 3, pp. 289–291, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Ziegler-Heitbrock, “The CD14+ CD16+ blood monocytes: their role in infection and inflammation,” Journal of Leukocyte Biology, vol. 81, no. 3, pp. 584–592, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Ziegler-Heitbrock, P. Ancuta, S. Crowe et al., “Nomenclature of monocytes and dendritic cells in blood,” Blood, vol. 116, no. 16, pp. e74–e80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Skrzeczyńska-Moncznik, M. Bzowska, S. Loseke, E. Grage-Griebenow, M. Zembala, and J. Pryjma, “Peripheral blood CD14high CD16+ monocytes are main producers of IL-10,” Scandinavian Journal of Immunology, vol. 67, no. 2, pp. 152–159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Urra, N. Villamor, S. Amaro et al., “Monocyte subtypes predict clinical course and prognosis in human stroke,” Journal of Cerebral Blood Flow and Metabolism, vol. 29, no. 5, pp. 994–1002, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Hristov and C. Weber, “Differential role of monocyte subsets in atherosclerosis,” Thrombosis and Haemostasis, vol. 106, no. 5, pp. 757–762, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Cros, N. Cagnard, K. Woollard et al., “Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors,” Immunity, vol. 33, no. 3, pp. 375–386, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Shantsila and G. Y. H. Lip, “Monocyte diversity in myocardial infarction,” Journal of the American College of Cardiology, vol. 54, no. 2, pp. 139–142, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Tsujioka, T. Imanishi, H. Ikejima et al., “Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction,” Journal of the American College of Cardiology, vol. 54, no. 2, pp. 130–138, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Nahrendorf, F. K. Swirski, E. Aikawa et al., “The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions,” Journal of Experimental Medicine, vol. 204, no. 12, pp. 3037–3047, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Tallone, G. Turconi, G. Soldati, G. Pedrazzini, T. Moccetti, and G. Vassalli, “Heterogeneity of human monocytes: an optimized four-color flow cytometry protocol for analysis of monocyte subsets,” Journal of Cardiovascular Translational Research, vol. 4, no. 2, pp. 211–219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Oikonomou, D. Tousoulis, G. Siasos, M. Zaromitidou, A. G. Papavassiliou, and C. Stefanadis, “The role of inflammation in heart failure: new therapeutic approaches,” Hellenic Journal of Cardiology, vol. 52, no. 1, pp. 30–40, 2011. View at Google Scholar · View at Scopus
  20. B. Passlick, D. Flieger, and H. W. Loms Ziegler-Heitbrock, “Identification and characterization of a novel monocyte subpopulation in human peripheral blood,” Blood, vol. 74, no. 7, pp. 2527–2534, 1989. View at Google Scholar · View at Scopus
  21. M. Moniuszko, A. Bodzenta-Lukaszyk, K. Kowal, D. Lenczewska, and M. Dabrowska, “Enhanced frequencies of CD14++CD16+, but not CD14+CD16+, peripheral blood monocytes in severe asthmatic patients,” Clinical Immunology, vol. 130, no. 3, pp. 338–346, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. S. M. Crowe and L. Ziegler-Heitbrock, “Editorial: monocyte subpopulations and lentiviral infection,” Journal of Leukocyte Biology, vol. 87, no. 4, pp. 541–543, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Nahrendorf, M. J. Pittet, and F. K. Swirski, “Monocytes: protagonists of infarct inflammation and repair after myocardial infarction,” Circulation, vol. 121, no. 22, pp. 2437–2445, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Barisione, S. Garibaldi, G. Ghigliotti et al., “CD14CD16 monocyte subset levels in heart failure patients,” Disease Markers, vol. 28, no. 2, pp. 115–124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. N. A. Skinner, C. M. MacIsaac, J. A. Hamilton, and K. Visvanathan, “Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens,” Clinical and Experimental Immunology, vol. 141, no. 2, pp. 270–278, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Yndestad, J. K. Damås, E. Oie, T. Ueland, L. Gullestad, and P. Aukrust, “Systemic inflammation in heart failure—the whys and wherefores,” Heart Failure Reviews, vol. 11, no. 1, pp. 83–92, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Braunwald, “Medical progress: biomarkers in heart failure,” New England Journal of Medicine, vol. 358, no. 20, pp. 2094–2159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. G. An, H. Wang, R. Tang et al., “P-selectin glycoprotein ligand-1 is highly expressed on ly-6Chi monocytes and a major determinant for ly-6Chi monocyte recruitment to sites of atherosclerosis in mice,” Circulation, vol. 117, no. 25, pp. 3227–3237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Wang, W. Luo, J. Wang et al., “Obesity-induced endothelial dysfunction is prevented by deficiency of P-selectin glycoprotein ligand-1,” Diabetes. In press.
  30. A. J. P. Clover, A. H. S. Kumar, and N. M. Caplice, “Deficiency of CX3CR1 delays burn wound healing and is associated with reduced myeloid cell recruitment and decreased sub-dermal angiogenesis,” Burns, vol. 37, no. 8, pp. 1386–1393, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. R. M. Tighe, Z. Li, E. N. Potts et al., “Ozone inhalation promotes CX3CR1-dependent maturation of resident lung macrophages that limit oxidative stress and inflammation,” Journal of Immunology, vol. 187, no. 9, pp. 4800–4808, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. P. M. Vidal, E. Lemmens, D. Dooley, and S. Hendrix, “The role of, “anti-inflammatory” cytokines in axon regeneration,” Cytokine & Growth Factor Reviews. In press.
  33. K. J. Pulkki, “Cytokines and cardiomyocyte death,” Annals of Medicine, vol. 29, no. 4, pp. 339–343, 1997. View at Google Scholar · View at Scopus
  34. K. Chatterjee and B. Massie, “Systolic and diastolic heart failure: differences and similarities,” Journal of Cardiac Failure, vol. 13, no. 7, pp. 569–576, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Niu and P. E. Kolattukudy, “Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications,” Clinical Science, vol. 117, no. 3, pp. 95–109, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Celik, A. Iyisoy, M. Celik, U. C. Yuksel, and E. Kardesoglu, “C-reactive protein in chronic heart failure: a new predictor of survival,” International Journal of Cardiology, vol. 135, no. 3, pp. 396–397, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Kleinbongard, R. Schulz, and G. Heusch, “TNFα in myocardial ischemia/reperfusion, remodeling and heart failure,” Heart Failure Reviews, vol. 16, no. 1, pp. 49–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Hedayat, M. J. Mahmoudi, N. R. Rose, and N. Rezaei, “Proinflammatory cytokines in heart failure: double-edged swords,” Heart Failure Reviews, vol. 15, no. 6, pp. 543–562, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Nishimura, T. Inoue, T. Nitto, T. Morooka, and K. Node, “Increased interleukin-13 levels in patients with chronic heart failure,” International Journal of Cardiology, vol. 131, no. 3, pp. 421–423, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. O. Amir, O. Rogowski, M. David, N. Lahat, R. Wolff, and B. S. Lewis, “Circulating interleukin-10: association with higher mortality in systolic heart failure patients with elevated tumor necrosis factor-alpha,” Israel Medical Association Journal, vol. 12, no. 3, pp. 158–162, 2010. View at Google Scholar · View at Scopus
  41. A. M. De Candia, H. Villacorta, and E. T. Mesquita, “Immune-inflammatory activation in heart failure,” Arquivos Brasileiros de Cardiologia, vol. 89, no. 3, pp. 201–208, 2007. View at Google Scholar · View at Scopus
  42. D. Cihakova, J. G. Barin, M. Afanasyeva et al., “Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation,” American Journal of Pathology, vol. 172, no. 5, pp. 1195–1208, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Borowski, M. Kuepper, U. Horn et al., “Interleukin-13 acts as an apoptotic effector on lung epithelial cells and induces pro-fibrotic gene expression in lung fibroblasts,” Clinical and Experimental Allergy, vol. 38, no. 4, pp. 619–628, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Purwar, M. Kraus, T. Werfel, and M. Wittmann, “Modulation of keratinocyte-derived MMP-9 by IL-13: a possible role for the pathogenesis of epidermal inflammation,” Journal of Investigative Dermatology, vol. 128, no. 1, pp. 59–66, 2008. View at Publisher · View at Google Scholar · View at Scopus